Why the study?
The aetiology of impaired autonomic modulation of HRV in PCOS and the impact of aerobic physical training on endocrine-metabolic disorders and HRV remain unclear, particularly given concurrent excess body fat.
Does aerobic physical training improve autonomic modulation of heart rate variability in women with polycystic ovary syndrome and varying levels of body fat?
Does aerobic physical training improve autonomic modulation of heart rate variability in women with polycystic ovary syndrome and varying levels of body fat?
Aerobic physical training partially reverses atypical sympathetic and vagal autonomic modulation in women with polycystic ovary syndrome, with effects varying by baseline body fat percentage.
Body fat may modulate autonomic responses to aerobic training in PCOS; hypothesis-generating, should not yet change practice.
OBJECTIVE: The aetiology of impairments in autonomic modulation of heart rate variability (HRV) in polycystic ovary syndrome (PCOS) remains unclear, as does the impact of aerobic physical training (APT) on controlling endocrine-metabolic disorders and HRV. This is because these women often present excess body fat. Therefore, we assessed whether the dysregulation in autonomic modulation of HRV in women with PCOS is due to endocrine-metabolic disorders and whether the combination of excess body fat with endocrine-metabolic disorders amplifies cardiovascular autonomic deficits. We also investigated whether APT positively influences autonomic modulation of HRV in PCOS. DESIGN: Non-randomised clinical trial. PARTICIPANTS: Women with and without PCOS with different percentages of body fat. MEASUREMENTS: Participants were divided into four groups: women without PCOS with a body fat percentage between 22% and 29% (CONTROL group; 22%-29%); CONTROL (30%-37%) group; PCOS (22%-29%) group; and PCOS (30%-37%) group. Hemodynamic, metabolic, and hormonal characteristics and HRV parameters were obtained before and after 16 weeks of APT. RESULTS: The PCOS (22%-29%) group exhibited lower vagal modulation than the CONTROL (22%-29%) group. In contrast, no significant differences were observed between the CONTROL (30%-37%) and PCOS (30%-37%) groups. Furthermore, the PCOS (30%-37%) group demonstrated lower sympathetic modulation than the PCOS (22%-29%) group. After APT, the PCOS (22%-29%) group increased in vagal modulation, while the PCOS (30%-37%) group increased in sympathetic modulation. CONCLUSION: PCOS affects vagal modulation; however, this effect may be masked at elevated levels of body fat. Additionally, the combination of excess body fat with endocrine-metabolic dysregulation appears to reduce sympathetic modulation, possibly due to sympathetic drive hyperactivity. APT positively affected HRV in both PCOS groups.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: